相关实验视频

Updated: Jun 28, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

CCND2是一种预后生物标志物,与肺腺癌中的免疫透相关

Erna Jia¹, Xianquan Shi², Jinru Xue³

¹Department of Gastroenterology, China-Japan Union Hospital of Jilin University, Changchun, China.

Translational cancer research

|April 15, 2024

概括

较低的CCND2表达与肺腺癌 (LUAD) 的生存率较差有关. 这项研究揭示了CCND2作为与LUAD免疫细胞透相关的预后生物标志物,提供了潜在的治疗策略.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学

背景情况:

环素D2 (CCND2) 影响癌细胞生长和瘤免疫反应.
关于CCND2在肺腺癌 (LUAD) 预后和免疫透中的作用的研究有限.

研究的目的:

调查CCND2表达和LUAD预后之间的相关性.
在LUAD中探索CCND2表达和瘤免疫透之间的关联.

主要方法:

从癌症基因组图谱 (TCGA) 中分析了LUAD组织中的CCND2表达.
通过Kaplan-Meier和Cox回归分析评估了CCND2表达和整体存活率之间的关系.
使用TIMER和CIBERSORTx数据库调查了CCND2与免疫透的联系.

主要成果:

与正常组织相比,LUAD组织中的CCND2表达显着较低.
较低的CCND2表达与较短的整体存活率相关,并将CCND2确定为LUAD的独立预后因素.
CCND2表达与各种免疫细胞积极相关,包括B细胞,CD8+ T细胞,CD4+ T细胞,巨细胞,中性粒细胞和髓状树突细胞.

结论:

在LUAD中,CCND2作为潜在的预后生物标志物.
CCND2与LUAD的免疫透格局有关.
研究结果表明,CCND2是新的LUAD预防和治疗策略的目标.

关键词:

CCND2 在线阅读免疫透免疫透是什么?肺腺癌 (LUAD) 是一种肺腺癌.预后预后预后

更多相关视频

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Quantification of Tumor Cell Adhesion in Lymph Node Cryosections

Published on: February 9, 2020

相关概念视频

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...